Drugs / Product 49778
last change Jan 2013 re-read 3 minutes ago

Product 49778

Developed for
seborrheic dermatitis
Investigated by
Medicis Global Service Corporation

Trials 1

201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT01703793 Sep 2012 → Jan 2013 seborrheic dermatitis Medicis Global Service Corporation Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Product 49778 ClinicalTrials.gov intervention name — accepted as the source's own label NCT01703793 ↗